Clinical Trial Update: Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

This document describes a Phase 4 clinical trial evaluating an acetylcysteine-containing triple therapy as first-line treatment for Helicobacter pylori infectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Acetylcysteine-containing triple therapy

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN